Literature DB >> 16807770

Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval.

M D Slater1, C R Murphy.   

Abstract

Prostate cancer is the most common cancer in American men and the second leading cause of cancer deaths in this group. Both growth hormone (GH) and the inflammatory cytokine interleukin 6 (IL-6) have been implicated in prostate cancer progression. Studies in other systems have shown that an increase in GH results in an increase in IL-6 also. The current study demonstrated a parallel spatial and temporal expression of GH and IL-6 in cells in prostate cancer glandular acina cells. This study cannot determine if this expression is coincidental or causative, but it seems likely that the increase in GH could induce the expression of IL-6, since this is the case in other tissues. Optimal labelling for IL-6 in our study was achieved with low pH, high temperature antigen retrieval.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16807770     DOI: 10.1007/s10735-006-9027-8

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  30 in total

1.  Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone.

Authors:  K K Kaulsay; H C Mertani; J Törnell; G Morel; K O Lee; P E Lobie
Journal:  Exp Cell Res       Date:  1999-07-10       Impact factor: 3.905

2.  High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland.

Authors:  M Raccurt; P E Lobie; E Moudilou; T Garcia-Caballero; L Frappart; G Morel; H C Mertani
Journal:  J Endocrinol       Date:  2002-11       Impact factor: 4.286

3.  Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone.

Authors:  Svetlana Mukhina; Hichem C Mertani; Ke Guo; Kok-Onn Lee; Peter D Gluckman; Peter E Lobie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

4.  Detection of apoptotic DNA damage in prostate hyperplasia using tyramide-amplified avidin-HRP.

Authors:  M Slater; C R Murphy
Journal:  Histochem J       Date:  1999-11

5.  Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue.

Authors:  A Hobisch; H Rogatsch; A Hittmair; D Fuchs; G Bartsch; H Klocker; G Bartsch; Z Culig
Journal:  J Pathol       Date:  2000-07       Impact factor: 7.996

6.  Interleukin-6 is an autocrine growth factor in human prostate cancer.

Authors:  D Giri; M Ozen; M Ittmann
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

7.  Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy.

Authors:  Lourdes Ibáñez; Alina Fucci; Carme Valls; Ken Ong; David Dunger; Francis de Zegher
Journal:  J Clin Endocrinol Metab       Date:  2005-03-08       Impact factor: 5.958

8.  Co-expression of GH and GHR isoforms in prostate cancer cell lines.

Authors:  L K Chopin; T L Veveris-Lowe; A F Philipps; A C Herington
Journal:  Growth Horm IGF Res       Date:  2002-04       Impact factor: 2.372

9.  Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer.

Authors:  John K Triantafillidis; Emmanuel Merikas; Vasillios Govosdis; Evangelia Konstandellou; Petros Cheracakis; Charalambos Barbatzas; Dimitrios Tzourmakliotis; George Peros
Journal:  Hepatogastroenterology       Date:  2003-12

10.  Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.

Authors:  Jae-Il Park; Min-Goo Lee; Kyucheol Cho; Bum-Joon Park; Kwon-Seok Chae; Do-Sun Byun; Byung-Kyu Ryu; Yong-Keun Park; Sung-Gil Chi
Journal:  Oncogene       Date:  2003-07-10       Impact factor: 9.867

View more
  6 in total

Review 1.  Extrapituitary growth hormone.

Authors:  S Harvey
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

2.  Androgen Receptor Regulation of Local Growth Hormone in Prostate Cancer Cells.

Authors:  M Victoria Recouvreux; J Boyang Wu; Allen C Gao; Svetlana Zonis; Vera Chesnokova; Neil Bhowmick; Leland W Chung; Shlomo Melmed
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

3.  Growth hormone is permissive for neoplastic colon growth.

Authors:  Vera Chesnokova; Svetlana Zonis; Cuiqi Zhou; Maria Victoria Recouvreux; Anat Ben-Shlomo; Takako Araki; Robert Barrett; Michael Workman; Kolja Wawrowsky; Vladimir A Ljubimov; Magdalena Uhart; Shlomo Melmed
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-25       Impact factor: 11.205

Review 4.  Growth hormone and reproduction: a review of endocrine and autocrine/paracrine interactions.

Authors:  Kerry L Hull; Steve Harvey
Journal:  Int J Endocrinol       Date:  2014-12-15       Impact factor: 3.257

5.  Expressions of IL-6, TNF-α and NF-κB in the skin of Chinese brown frog (Rana dybowskii).

Authors:  Liqin Xi; Chen Wang; Pengyu Chen; Qi Yang; Ruiqi Hu; Haolin Zhang; Qiang Weng; Meiyu Xu
Journal:  Eur J Histochem       Date:  2017-10-19       Impact factor: 3.188

Review 6.  Role of anabolic agents in colorectal carcinogenesis: Myths and realities (Review).

Authors:  Theodore Krasanakis; Taxiarchis Konstantinos Nikolouzakis; Markos Sgantzos; Theodore Mariolis-Sapsakos; John Souglakos; Demetrios A Spandidos; Christina Tsitsimpikou; Aristidis Tsatsakis; John Tsiaoussis
Journal:  Oncol Rep       Date:  2019-10-03       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.